Apolipoprotein E controls the risk and age at onset of Parkinson disease.
Neurology
; 62(11): 2005-9, 2004 Jun 08.
Article
em En
| MEDLINE
| ID: mdl-15184605
ABSTRACT
BACKGROUND:
Similarities between Alzheimer disease (AD) and Parkinson disease (PD) suggest a possible role for apolipoprotein E (APOE) in PD. Most previous studies seeking to establish such a link used case-control datasets and results have been inconsistent.OBJECTIVE:
To investigate APOE's role in PD using family-based association analyses.METHODS:
APOE functional polymorphisms were genotyped for 658 PD affected families, including 282 multiplex and 376 singleton families. The pedigree disequilibrium test (PDT) and the genotype-PDT were used to test the risk effect of APOE. The Monks-Kaplan test was used to evaluate the effect of APOE on age at onset of PD.RESULTS:
APOE was significantly associated with risk of developing PD. Stratified analysis revealed that APOE was most strongly associated with families with a positive PD family history (global p = 0.003). Like AD, the APOE-4 allele increases disease risk while the APOE-3 allele decreases risk. We detected a positive association of APOE-3 (p = 0.019) and a negative association of APOE-4 (p = 0.015) with age at onset in PD.CONCLUSIONS:
The APOE-4 allele increases risk and decreases age at onset of PD, an association that may not be dependent upon cognitive impairment.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Doença de Parkinson
/
Apolipoproteínas E
Idioma:
En
Ano de publicação:
2004
Tipo de documento:
Article